Cornea/External Disease News

The Prosthetic Replacement of Ocular Surface Ecosystem was well-tolerated and appeared efficacious as a delivery system for preservative-free cyclosporine 0.05% in the treatment of dry eye disease, according to results of a pilot study.

The FDA cleared the Epithelial Thickness Module for the Anterion cornea app from Heidelberg Engineering, according to a press release.

Cold instillation of a cyclosporine A solution reduced instillation discomfort among patients with dry eye disease, with results lasting up to 9 minutes, according to research published in Optometry and Vision Science.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Sheri Rowen, MD, of NVISION Eye Centers, discusses the link between dry eye disease and menopause.

The Olympics, natural events and Supreme Court decisions have not only made history this year, they have touched the world of eye care.

Alcon Laboratories announced the voluntary recall of one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, following a consumer complaint that led to the discovery of fungal contamination in the drops.

The American Optometric Association Health Policy Institute has released a new brief to educate the public on blepharitis, its symptoms and treatment options.

Glaukos submitted a new drug application to the FDA for Epioxa, an epithelium-on corneal cross-linking iLink therapy for the treatment of keratoconus, according to a company press release.

Every year Healio covers a wide range of optometry-related news from the FDA, and 2024 was no exception.